Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Anagenics Limited ( (AU:AN1) ) has shared an announcement.
Anagenics Limited reported a significant improvement in its net operating cash flow for the quarter ending December 31, 2024, with a reduction in outflow from $0.9 million in the first quarter to $0.3 million in the second quarter. This positive change is attributed to effective restructuring activities, including a substantial decrease in costs related to advertising, staff, and corporate administration. The company expects to fully realize the benefits of these changes in the following quarter. Additionally, Anagenics is working towards reinstating its securities for quotation by the end of February 2025, following a voluntary suspension.
More about Anagenics Limited
Anagenics Limited is a company operating in the health, beauty, and wellness industry, focusing on growing shareholder value through global distribution and sales of proprietary and licensed brands. The company offers differentiated, clinically validated anti-aging solutions, with its subsidiary BLC Cosmetics Pty Ltd handling the sales and distribution of leading Australian and international cosmetic and wellness products.
Current Market Cap: A$3.69M
See more data about AN1 stock on TipRanks’ Stock Analysis page.
